Barclays Maintains an 'Overweight' on Dun & Bradstreet (DNB); Asking The Tough Questions

May 10, 2012 3:07 PM EDT
Get Alerts DNB Hot Sheet
Price: $122.74 +1.18%

Rating Summary:
    2 Buy, 5 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade DNB Now!
Join SI Premium – FREE
Barclays maintains an 'Overweight' on Dun & Bradstreet (NYSE: DNB) price target lowered from $92 to $80.

Analyst, Manav Patnaik, said, "DNB is economically sensitive and 1Q12 showed it. The impact on the shares, while might seem overdone, was likely deserved as (1) its core North America (N.A.) Risk management (RMS) business was the area of weakness and (2) the company still does not have a clear path of new product innovation to reinvigorate this unit (at least not in 2012)."

Patnaik did however, bring up a critical point to DNB the company better off private? Patnaik believes opportunities exist for the company, but feels DNB management need to re-assess valuation, calling this 're-assessment' the barrier to a sale.

FY12 EPS estimates are lowered from $6.51 to $6.43, but FY13 are raised from $7.16 to $7.25.

In the end, the Barclays analyst, said that any investor with a long-term time horizon, may consider accumulating shares at current levels.

For an analyst ratings summary and ratings history on Dun & Bradstreet click here. For more ratings news on Dun & Bradstreet click here.

Shares of Dun & Bradstreet closed at $63.34 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities


Add Your Comment